The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial-Reference-Cited by-同舟云学术

The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial

Published:2023-12-14 Issue: Volume: Page:
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Saber-Moghaddam Niloufar,Nodeh Mohammad Moeini,Ghavami Vahid,Rahimi Hossein,Azimi Sajjad Ataei,Seddigh-Shamsi Mohsen,Kamandi Mostafa,Allahyari Abolghasem,Shariatmaghani Somayeh Sadat,Elyasi Sepideh,Arasteh Omid

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00210-023-02892-w.pdf

Reference61 articles.

1. al-jubouri MA, Briston PG, Sinclair D, Chinn RH, Young RM (1994) Myxoedema revealed by simvastatin induced myopathy. BMJ 308(6928):588

2. Atilla A, Çelik M, Çolak ÖY, Kuruoğlu T, Temoçin F, Kelkitli E, Birinci A (2022) Hematolojik Maligniteli Hastalarda İnvaziv Küf Enfeksiyonları: Çevresel Faktörlerin Etkisi [Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors]. Mikrobiyol Bul 56(2):315–325. https://doi.org/10.5578/mb.20229810

3. Auberger J, Lass-Flörl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, Einsele H, Gastl G, Nachbaur D (2008) Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 88(5):508–515

4. Baker SK, Goodwin S, Sur M, Tarnopolsky MA (2004) Cytoskeletal myotoxicity from simvastatin and colchicine. Muscle Nerve 30(6):799–802. https://doi.org/10.1002/mus.20135

5. Bow EJ, Loewen R, Cheang MS, Schacter B (1995) Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 21(2):361–369